In Israel, Hod et al. [82] conducted a small RCT (N = 322 women) comparing the impact on fetal and perinatal outcomes of insulin aspart, a fast-acting insulin analogue, versus human insulin therapy in women with pre-gestational diabetes. This evidence concerns the gene INS and gestational diabetes.